Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.710
-0.060 (-3.39%)
At close: Feb 27, 2026, 4:00 PM EST
1.720
+0.010 (0.58%)
After-hours: Feb 27, 2026, 7:51 PM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $455.11 million as of February 27, 2026. Its market cap has decreased by -12.75% in one year.
Market Cap
455.11M
Enterprise Value
412.87M
1-Year Change
-12.75%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $455.11M, a decrease of -53.07%. That is a compound annual growth rate of -9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 455.11M | -14.07% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 488.82M |
| vTv Therapeutics | 487.92M |
| Invivyd | 479.38M |
| Tenax Therapeutics | 476.70M |
| Lineage Cell Therapeutics | 474.96M |
| Larimar Therapeutics | 472.46M |
| Assembly Biosciences | 468.03M |
| Prothena Corporation | 465.09M |